Company / Operating Margin
CHAMPIONS ONCOLOGY, INC. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-14.7%
FY2025
5-year range
-14.7% / 8.0%
FY2021-FY2025
Trend
-283.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -283% YoY in FY2025, a notable deviation from the 9-year average annual change of -7%.
Based on SEC 10-K filings.
-14.7% in FY2025 with a 5-year CAGR of -15.6%.
Declined from 1.2% to -14.7% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -15.6pp
- 5-Year Change
- -15.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 283.4% year-over-year.
- Peak operating margin was recorded in FY2024.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -14.7% | -283.4% |
| FY2024 | 8.0% | +545.2% |
| FY2023 | 1.2% | +39.3% |
| FY2022 | 0.9% | +114.9% |
| FY2021 | -6.0% | -771.9% |
| FY2020 | 0.9% | +114.9% |
| FY2019 | -6.0% | +86.5% |
| FY2018 | -44.2% | +52.1% |
| FY2017 | -92.3% | +38.2% |
| FY2016 | -149.4% | -175.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026